TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30106335

Group type: EXPERIMENTAL
Intervention: Whitening dentifrice containing blue covarine (group CU)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Conventional whitening dentifrice (group CW)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Regular dentifrice (group C)
Number of subjects: 60
Study: 29768147

Group type: EXPERIMENTAL
Intervention: Budesonide-formoterol used as needed (200 μg of budesonide and 6 μg of formoterol)
Number of subjects: 4176

Group type: COMPARATOR
Intervention: Budesonide maintenance therapy (200 μg of budesonide plus terbutaline 0.5 mg used as needed)
Number of subjects: 4176

Group type: EXPERIMENTAL
Intervention: Budesonide-formoterol used as needed
Number of subjects: 4176

Group type: COMPARATOR
Intervention: Budesonide maintenance therapy
Number of subjects: 4176
Study: 27001560

Group type: EXPERIMENTAL
Intervention: Gum chewing
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Bed exercises
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control (routine treatment and care)
Number of subjects: 120
Study: 24907403

Group type: EXPERIMENTAL
Intervention: Pregabalin (150-600 mg/day)
Number of subjects: 377

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 377
Study: 23157902

Group type: EXPERIMENTAL
Intervention: Clopidogrel alone (group A)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Clopidogrel combined with warfarin (group B)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Critical limb ischemia subgroup analysis (group A)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Critical limb ischemia subgroup analysis (group B)
Number of subjects: 50
Study: 20947571

Group type: EXPERIMENTAL
Intervention: PhD algorithm for detecting HF events
Number of subjects: 214
Study: 17106432

Group type: EXPERIMENTAL
Intervention: Gabapentin 1800 mg daily
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study: 11420479

Group type: EXPERIMENTAL
Intervention: Electrothermal device for sutureless closed hemorrhoidectomy
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional open Milligan‐Morgan hemorrhoidectomy
Number of subjects: 80
Study: 9192239

Group type: EXPERIMENTAL
Intervention: Cryoablation using CO2 at -60 degrees C for 120 sec (group A)
Number of subjects: 20

Group type: COMPARATOR
Intervention: No cryoablation (group B)
Number of subjects: 20
Study: 8516491

Group type: EXPERIMENTAL
Intervention: Nitrendipine
Number of subjects: 34
Study: 3826269

Group type: EXPERIMENTAL
Intervention: Body mechanics instruction
Number of subjects: 30

Group type: COMPARATOR
Intervention: No instruction (Control)
Number of subjects: 30
Study: 30340476

Group type: EXPERIMENTAL
Intervention: Severity of Dependence Scale for Khat (SDS-Khat)
Number of subjects: 178
Study: 28039085

Group type: EXPERIMENTAL
Intervention: Active infrared laser stimulation to the lateral prefrontal cortex
Number of subjects: 118

Group type: COMPARATOR
Intervention: Sham (placebo) stimulation
Number of subjects: 118
Study: 26231133

Group type: EXPERIMENTAL
Intervention: Standardized physical examination including carotid Doppler ultrasonography, echocardiography, electrocardiography, blood pressure monitoring, pulse rate, urine analysis, body mass index analysis, and laboratory tests.
Number of subjects: 77
Study: 23997137

Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression (IPC) of the foot for at least six hours daily under a plaster cast for two weeks
Number of subjects: 26

Group type: COMPARATOR
Intervention: No additional treatment (Control)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression (IPC) of the foot
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Malfunction of IPC
Number of subjects: 26
Study: 21159527

Group type: EXPERIMENTAL
Intervention: Supervised exercise therapy (SET)
Number of subjects: 304

Group type: COMPARATOR
Intervention: Go home and walk advice (WA)
Number of subjects: 304
Study: 18348595

Group type: EXPERIMENTAL
Intervention: Paroxetine CR
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 17726216

Group type: EXPERIMENTAL
Intervention: Intraoperative adjustable suture technique
Number of subjects: 88

Group type: COMPARATOR
Intervention: Fixed conventional suture technique
Number of subjects: 88
Study: 12703846

Group type: EXPERIMENTAL
Intervention: Hamstring stretches (3 bouts of 20 seconds)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Rest (no stretching)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Stretch condition
Number of subjects: 32

Group type: COMPARATOR
Intervention: Non-stretch condition
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Females (irrespective of stretch condition)
Number of subjects: 32
Study: 10763937

Group type: EXPERIMENTAL
Intervention: Successful H. pylori eradication (63 patients, 72%)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Failed H. pylori eradication (24 patients, 28%)
Number of subjects: 87
Study: 8878342

Group type: EXPERIMENTAL
Intervention: Citalopram (20 mg, acute dose)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Citalopram (20 mg/day for 14 days, chronic dose)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 1447078

Group type: EXPERIMENTAL
Intervention: Large volume of fluid (LF)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Moderate volume of fluid (MF)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Small volume of fluid (SF)
Number of subjects: 8

Group type: COMPARATOR
Intervention: No fluid (NF)
Number of subjects: 8
Study: 29627346

Group type: EXPERIMENTAL
Intervention: 10% SSB price increase
Number of subjects: 2020

Group type: EXPERIMENTAL
Intervention: 20% SSB price increase
Number of subjects: 2020

Group type: EXPERIMENTAL
Intervention: Educational poster exposure
Number of subjects: 2020
Study: 27741345

Group type: EXPERIMENTAL
Intervention: Efinaconazole topical solution (10%)
Number of subjects: 0
Study: 24038028

Group type: EXPERIMENTAL
Intervention: Higher doses of corticosteroid
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Promoter variations in intrinsic apoptosis genes
Number of subjects: 0
Study: 22647787

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 322

Group type: COMPARATOR
Intervention: Carvedilol
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: Both Metoprolol and Carvedilol
Number of subjects: 322
Study: 20028946

Group type: EXPERIMENTAL
Intervention: Insulin and glucose infusion (euglycemic-hyperinsulinemic clamp)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Insulin and glucose infusion plus Intralipid and heparin infusion
Number of subjects: 6

Group type: COMPARATOR
Intervention: Saline control
Number of subjects: 6
Study: 17985382

Group type: EXPERIMENTAL
Intervention: Export-Medtronic (EM)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Diver-Invatec (DI)
Number of subjects: 103
Study: 17010005

Group type: EXPERIMENTAL
Intervention: Naftopidil monotherapy (25-75 mg/day)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Combination therapy (25-75 mg/day of naftopidil and 10-20 mg/day of propiverine hydrochloride or 2-6 mg/day of oxybutynin hydrochloride)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Combination therapy
Number of subjects: 101
Study: 12705171

Group type: EXPERIMENTAL
Intervention: 0.05% azelastine eye drops, twice daily
Number of subjects: 116

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116
Study: 10632236

Group type: EXPERIMENTAL
Intervention: Sertraline (up to 200 mg/d)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Desipramine (up to 300 mg/d)
Number of subjects: 166
Study: 8719717

Group type: EXPERIMENTAL
Intervention: Routine ultrasound examination during gestational week 18 with additional information on alternatives (early abdominal ultrasound, both routine ultrasound and amniocentesis).
Number of subjects: 2412

Group type: COMPARATOR
Intervention: Standard information provided at control antenatal clinics.
Number of subjects: 2412
Study: 1330434

Group type: EXPERIMENTAL
Intervention: 20-40 mg/day lovastatin
Number of subjects: 919

Group type: EXPERIMENTAL
Intervention: 1 mg/day (minidose) warfarin
Number of subjects: 919

Group type: EXPERIMENTAL
Intervention: Combination of 20-40 mg/day lovastatin and 1 mg/day warfarin
Number of subjects: 919

Group type: COMPARATOR
Intervention: Lovastatin placebo
Number of subjects: 919

Group type: COMPARATOR
Intervention: Warfarin placebo
Number of subjects: 919

Group type: EXPERIMENTAL
Intervention: Low-dose (81 mg/day) aspirin
Number of subjects: 919
Study: 2983630

Group type: EXPERIMENTAL
Intervention: Caffeine (10 mg/kg)
Number of subjects: 38
Study: 31476901

Group type: EXPERIMENTAL
Intervention: AVS-guided adrenalectomy
Number of subjects: 1625

Group type: COMPARATOR
Intervention: Non AVS-guided adrenalectomy
Number of subjects: 1625

Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 1625
Study: 29800048

Group type: EXPERIMENTAL
Intervention: 1% rapamycin
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: 0.1% rapamycin
Number of subjects: 179

Group type: COMPARATOR
Intervention: Vehicle only
Number of subjects: 179
Study: 27281542

Group type: EXPERIMENTAL
Intervention: Weight loss intervention (diet and exercise)
Number of subjects: 32
Study: 25262260

Group type: EXPERIMENTAL
Intervention: Peak CK-MB concentration
Number of subjects: 1799

Group type: EXPERIMENTAL
Intervention: Area under the time-concentration curve (AUC)
Number of subjects: 1799

Group type: EXPERIMENTAL
Intervention: AUC
Number of subjects: 1799
Study: 22241144

Group type: EXPERIMENTAL
Intervention: 100% oxygen for 15 min
Number of subjects: 38

Group type: COMPARATOR
Intervention: Room air
Number of subjects: 38

Group type: COMPARATOR
Intervention: 100% oxygen
Number of subjects: 38
Study: 19243753

Group type: EXPERIMENTAL
Intervention: Combination hormone therapy (HT), 5 microg ethinyl E(2) and 1 mg norethindrone acetate for 4 weeks
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo for 4 weeks
Number of subjects: 10
Study: 18498416

Group type: EXPERIMENTAL
Intervention: Egg group (muffin containing one egg)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (egg-free muffin)
Number of subjects: 32
Study: 15819765

Group type: EXPERIMENTAL
Intervention: Fentanyl 15 microg (F)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Diamorphine 0.25 mg (D)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Fentanyl 15 microg plus diamorphine 0.25 mg (FD)
Number of subjects: 99
Study: 11899505

Group type: EXPERIMENTAL
Intervention: Albumin infusion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Albumin infusion with large-volume paracentesis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Albumin infusion in selected patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Albumin infusion with vasopressin analogue
Number of subjects: 0
Study: 10980827

Group type: EXPERIMENTAL
Intervention: C-reactive protein (CRP) as a marker of sub-clinical atherosclerosis and cardiovascular risk
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Secondary preventive therapies (statin drugs and aspirin)
Number of subjects: 0
Study: 7669490

Group type: COMPARATOR
Intervention: R 56865 (20 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: R 56865 (30 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: R 56865 (40 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 2288834

Group type: EXPERIMENTAL
Intervention: Oral administration of eltoprazine (8 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Intravenous administration of eltoprazine (3 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Intravenous administration of eltoprazine (8 mg)
Number of subjects: 12
Study: 7026073

Group type: EXPERIMENTAL
Intervention: Chemotherapy plus mastectomy (surgery)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Chemotherapy plus radiotherapy
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Both treatment groups (chemotherapy plus mastectomy and chemotherapy plus radiotherapy)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Both treatment groups
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Surgical group (chemotherapy plus mastectomy)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Surgery versus radiotherapy
Number of subjects: 132
Study: 31460627

Group type: EXPERIMENTAL
Intervention: Satisfaction scale for outpatient care users (ESCOMA)
Number of subjects: 13814

Group type: EXPERIMENTAL
Intervention: Confirmatory factor analysis (CFA) model
Number of subjects: 13814

Group type: EXPERIMENTAL
Intervention: Measurement invariance analysis
Number of subjects: 13814

Group type: EXPERIMENTAL
Intervention: Reliability assessment using McDonald's Omega Coefficient (ω)
Number of subjects: 13814
Study: 28705314

Group type: EXPERIMENTAL
Intervention: Usual care plus palliative care intervention (UC + PAL)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 150
Study: 25319251

Group type: EXPERIMENTAL
Intervention: CTP-based selection (n=47)
Number of subjects: 776

Group type: COMPARATOR
Intervention: MRI-based selection (n=16)
Number of subjects: 776

Group type: EXPERIMENTAL
Intervention: CTP acquisition/processing
Number of subjects: 776

Group type: EXPERIMENTAL
Intervention: Mismatch classification
Number of subjects: 776

Group type: EXPERIMENTAL
Intervention: CTP acquisition time
Number of subjects: 776

Group type: EXPERIMENTAL
Intervention: RAPID processing time
Number of subjects: 776
Study: 23407100

Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy (ART)
Number of subjects: 461
Study: 21078950

Group type: EXPERIMENTAL
Intervention: PNU-100480 at 600 mg twice daily for 28 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PNU-100480 with pyrazinamide on days 27 and 28
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Linezolid at 300 mg daily for 4 days
Number of subjects: 0
Study: 19377083

Group type: EXPERIMENTAL
Intervention: Polarity Therapy (PT)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Enhanced Respite Control (ERC)
Number of subjects: 42
Study: 17680858

Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting stent (PES)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Bare metal stent (BMS)
Number of subjects: 80
Study: 16391480

Group type: EXPERIMENTAL
Intervention: Geowave device in geopathic zone
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Geowave device in neutral zone
Number of subjects: 52

Group type: COMPARATOR
Intervention: Geopathic zone without Geowave device
Number of subjects: 52

Group type: COMPARATOR
Intervention: Neutral zone without Geowave device
Number of subjects: 52
Study: 12014063

Group type: EXPERIMENTAL
Intervention: Fexofenadine 180 mg OD for 3 weeks followed by randomization to fexofenadine or placebo for another 3 weeks
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 10221688

Group type: EXPERIMENTAL
Intervention: Trimegestone (various doses) with micronized oestradiol (2 mg/day)
Number of subjects: 203
Study: 8536299

Group type: COMPARATOR
Intervention: Migraineurs without aura
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 75

Group type: COMPARATOR
Intervention: Migraineurs with aura
Number of subjects: 75
Study: 2344316

Group type: EXPERIMENTAL
Intervention: Plantar tap method
Number of subjects: 110

Group type: COMPARATOR
Intervention: Tendon tap method
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Both methods
Number of subjects: 110
Study: 7405974

Group type: EXPERIMENTAL
Intervention: 50 microgram estrogen
Number of subjects: 32

Group type: COMPARATOR
Intervention: 20 microgram estrogen
Number of subjects: 32
Study: 31688930

Group type: EXPERIMENTAL
Intervention: Nicotine-salt pod system (NSPS)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Cigarette smoking
Number of subjects: 90

Group type: COMPARATOR
Intervention: Cigarette abstinence
Number of subjects: 90
Study: 30431426

Group type: EXPERIMENTAL
Intervention: FS Spiromax 500/50 µg
Number of subjects: 156

Group type: COMPARATOR
Intervention: Seretide Accuhaler 50/500 µg
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: FS Spiromax 500/50 µg with charcoal block
Number of subjects: 156

Group type: COMPARATOR
Intervention: Seretide Accuhaler 50/500 µg with charcoal block
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: FS Spiromax
Number of subjects: 156

Group type: COMPARATOR
Intervention: Seretide Accuhaler
Number of subjects: 156
Study: 27981744

Group type: EXPERIMENTAL
Intervention: Enhanced stretching intervention with individual phone counseling and SMS support for 12 weeks, followed by acculturation workshops for weeks 13-24
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard stretching intervention, structured 6 min stretching exercise program for at least three times per day and 5 days per week
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Enhanced stretching intervention
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard stretching intervention
Number of subjects: 80
Study: 25266608

Group type: EXPERIMENTAL
Intervention: Vigorous-intensity exercise
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Light-intensity exercise
Number of subjects: 40

Group type: COMPARATOR
Intervention: Vigorous-intensity exercise vs Light-intensity exercise
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Exercise (all intensities)
Number of subjects: 40
Study: 24306710

Group type: EXPERIMENTAL
Intervention: Arthroscopic Surgery Skill Evaluation Tool (pass-fail examination)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Logging more than eighty arthroscopic cases or performing more than thirty-five arthroscopic knee cases
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Interclass correlation coefficient
Number of subjects: 30
Study: 21278321

Group type: EXPERIMENTAL
Intervention: Motivational intervention group
Number of subjects: 245

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 245
Study: 19278844

Group type: EXPERIMENTAL
Intervention: Very-low-calorie diet (VLCD) and weight maintenance (WM) with 120mg orlistat
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo during weight maintenance (WM)
Number of subjects: 35
Study: 16903597

Group type: EXPERIMENTAL
Intervention: Scraping therapy and warming acupuncture-moxibustion
Number of subjects: 100

Group type: COMPARATOR
Intervention: Simple acupuncture (Control)
Number of subjects: 100
Study: 15023755

Group type: EXPERIMENTAL
Intervention: Sentinel node biopsy (SNB) followed by immediate axillary clearance (AC)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Sentinel node biopsy (SNB) followed by axillary clearance only if the SNB specimen is positive
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Immediate axillary clearance (AC)
Number of subjects: 1000
Study: 10892875

Group type: EXPERIMENTAL
Intervention: Computer-assisted quantitation of CNV
Number of subjects: 5

Group type: COMPARATOR
Intervention: Standard methods for CNV identification
Number of subjects: 5
Study: 9196866

Group type: EXPERIMENTAL
Intervention: Contrast enhanced MRI assessment
Number of subjects: 31

Group type: COMPARATOR
Intervention: Conventional radiography (x-ray)
Number of subjects: 31
Study: 2006357

Group type: EXPERIMENTAL
Intervention: Piecewise exponential survival model
Number of subjects: 0

Group type: COMPARATOR
Intervention: Piecewise exponential Cox model
Number of subjects: 0
Study: 6315050

Group type: EXPERIMENTAL
Intervention: Wholemeal bread (phytate 2.2 mmol, non-starch polysaccharide 18.7 g)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Brown bread (phytate 2.1 mmol, non-starch polysaccharide 10.9 g)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: White bread (phytate 2.3 mmol, non-starch polysaccharide 3.3 g)
Number of subjects: 6
Study: 31092142

Group type: EXPERIMENTAL
Intervention: tDCS
Number of subjects: 26
Study: 29428473

Group type: EXPERIMENTAL
Intervention: Mesorectal excision alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mesorectal excision with lateral lymph node dissection
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Blood loss ≥500 mL
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tumor location in lower rectum
Number of subjects: 0
Study: 26374448

Group type: EXPERIMENTAL
Intervention: Weight gain (5% of body weight by 8 weeks of overfeeding)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Weight maintenance (control group)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Leptin (in vitro experiments)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Leptin antagonist (in vitro experiments)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Adipose tissue from normal-weight participants
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Adipose tissue from obese participants
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Caveolin-1 expression in obese subjects
Number of subjects: 44
Study: 25259469

Group type: EXPERIMENTAL
Intervention: Plyometrics (PG)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Combined training (CG)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: In-water-specific strength (WSG)
Number of subjects: 30
Study: 22269592

Group type: EXPERIMENTAL
Intervention: Positive-affect induction and self-affirmation (PA)
Number of subjects: 256

Group type: COMPARATOR
Intervention: Patient education (PE)
Number of subjects: 256
Study: 20169360

Group type: EXPERIMENTAL
Intervention: DASH plus moderate intensity resistance training (DASH-RT)
Number of subjects: 27

Group type: COMPARATOR
Intervention: DASH (control group)
Number of subjects: 27
Study: 19180337

Group type: EXPERIMENTAL
Intervention: Oscillating positive expiratory pressure maneuvers followed by forced expiratory technique sequences with inhaled hypertonic saline (3%, 4% or 5%) in asthma patients (A/I)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Oscillating positive expiratory pressure maneuvers followed by forced expiratory technique sequences with inhaled hypertonic saline (3%, 4% or 5%) in COPD patients (C/I)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Standard induced sputum protocol in asthma patients (A/C)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Standard induced sputum protocol in COPD patients (C/C)
Number of subjects: 26
Study: 15736159

Group type: EXPERIMENTAL
Intervention: Dysport (500 units)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 12462513

Group type: EXPERIMENTAL
Intervention: Nonpharmacological treatment (vagal tone increase)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Nonpharmacological treatment (little change in vagal tone)
Number of subjects: 16